Genomics Institute of the Novartis Research Foundation
Imidazolepyridine compounds and uses thereof
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R3, R4, R6, and R7 are as defined herein. 
Novartis AG
A C
A61P C07D
inventional inventional
Zhengtian Wei Ling Long Martin Ho Man Xingnian Kehao Man Ying Yongfeng Yuan Ji Yue Hailong Xiang-Ju Justin Qiong
Yu Qi Li Wang Sendzik Chan Fu Zhao Zhang Huang Sun Mi Zhang Zhang Gu Zhang